N
ZBIO

Nuveen’s Zenas BioPharma ZBIO Stock Holding History

Nuveen’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Buy
67,770
+16,920
+33% +$380K ﹤0.01% 2452
2025
Q4 		$1.85M Buy
50,850
+30,331
+148% +$998K ﹤0.01% 2323
2025
Q3 		$456K Sell
20,519
-11,107
-35% -$181K ﹤0.01% 2927
2025
Q2 		$306K Hold
31,626
– – ﹤0.01% 3045
2025
Q1 		$250K Buy
31,626
+11,717
+59% +$91.7K ﹤0.01% 3074
2024
Q4 		$163K Buy
+19,909
New +$311K ﹤0.01% 3235

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Nuveen's ZBIO Position: Q1 2026 in Review

Nuveen increased its Zenas BioPharma (ZBIO) stake by 33% in Q1 2026, buying an estimated $380K and bringing the position to 67,770 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

Nuveen first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.85M in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Nuveen held 67,770 shares of Zenas BioPharma worth $1.32M as of Q1 2026.
  • Nuveen bought 16,920 Zenas BioPharma shares in Q1 2026, an estimated $380K.
  • Zenas BioPharma made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2452 holding.
  • Nuveen first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
  • Nuveen's Zenas BioPharma position peaked at $1.85M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.